BZAM initiated with a Speculative Buy at Clarus

Clarus initiated coverage of BZAM with a Speculative Buy rating and C$0.65 price target. Formerly The Green Organic Dutchman, the company, one of Canada’s "oldest and best-known" licensed producers of cannabis, substantially increased its product portfolio through an October 2022 merger with privately-held BZAM and sourced a billionaire backer who is now Chairman, the analyst tells investors. The firm calls this deal a "model merger" in the Canadian cannabis LP sector, given that two "sizable companies with limited product or geographic overlap" came together to drive economies of scale.